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Abstract 
Trend analysis in 2005 to 2011 showed high growth in diabetes prevalence in Iran. Considering the high 
prevalence of diabetes in the country and likely to increase its prevalence in the future, the analysis of 
diabetes-related policies and programs is very important and effective in the prevention and control of diabetes. 
Therefore, the aim of the study was an analysis of policies and programs related to prevention and control of 
diabetes in Iran in 2014. 
This study was a policy analysis using deductive thematic content analysis of key documents. The health policy 
triangle framework was used in the data analysis. PubMed and ScienceDirect databases were searched to find 
relevant studies and documents. Also, hand searching was conducted among references of the identified studies. 
MAXQDA 10 software was used to organize and analyze data. 
The main reasons to take into consideration diabetes in Iran can be World Health Organization (WHO) report in 
1989, and high prevalence of diabetes in the country. The major challenges in implementing the diabetes 
program include difficulty in referral levels of the program, lack of coordination between the private sector and 
the public sector and the limitations of reporting system in the specialized levels of the program. 
Besides strengthening referral system, the government should allocate more funds to the program and more 
importance to the educational programs for the public. Also, Non-Governmental Organizations (NGOs) and the 
private sector should involve in the formulation and implementation of the prevention and control programs of 
diabetes in the future. 
Keywords: diabetes, document analysis, Iran, policy analysis  
1. Introduction  
Islamic Republic of Iran, a country in the Middle East, has 75 million people, according to the last national 
census in 2011 (Statistical Center of Iran (SCI), October 24 2011). The urban and rural population of the country, 
in accordance with the same census, is 72% and 28%, respectively. Iran, similar to most developing countries, is 
in epidemiological transition. The Non-Communicable Diseases (NCDs) such as diabetes are replacing 
infectious diseases as the main causes of mortality and morbidity in developing countries. So that, 80% of NCDs 
deaths in the world occur in these countries (Golozar et al., 2011). 
Diabetes is one of the most common NCDs worldwide. Seventy percent of people with diabetes lived in Low 
and Middle Income Countries (LMICs) in 2010 and the highest relative increase in the diabetes burden happens 
in Africa and the Middle East (Golozar et al., 2011). It is predicted to increase the diabetes prevalence in the 
developing countries up to 15% in the next 25 year. Most of this increase will occur in people aged 35 to 64 
years old, whereas most people with diabetes in the developed countries are above the retirement age. So, the 
problem will more complicate in the developing countries (Wild et al., 2004). 
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First study about the diabetes prevalence in the country dates back to 1977. This study was conducted by the 
Iran’s Institute of Nutrition and Food Sciences on 6300 people. The results of the study showed increases of 
diabetes in employees compared to workers, as well as a high prevalence of diabetes in the desert areas of Iran. 
Also, the diabetes prevalence in the study was reported in children and adults 0.6–0.005 and 2–10 %, 
respectively (Azizi et al., 2003b).  
Next study about the prevalence of diabetes was carried out by the research deputy of the Ministry of Health and 
Medical Education (MoHME) in 1990. The research results indicated the highest prevalence of diabetes in 
Tehran (capital of Iran). Also, the diabetes prevalence in the cities was more than the villages and in women 
more than in men. The study results were not reliable, because of collecting data from a questionnaire and lack 
of an indicator to measure blood glucose (Azizi et al., 2003a). 
Systematic epidemiological studies were launched by the Endocrine Research Center and Institute of Food 
Technology, Shahid Beheshti University of Medical Sciences, on the people older than 30 years in Islamshahr (a 
city near Tehran) in 1993. The results of these studies showed that the diabetes prevalence was in women and 
men about 7.6% and 8.9, respectively, and also half of diabetic patients were unaware of their disease (Azizi et 
al., 2003c). Subsequent study based on the results of the Iran’s first survey of NCDs risk factors in 2006 showed 
that the diabetes prevalence was 7.7% (Delavari et al., 2005). 
According to the latest studies in Iran, prevalence of diabetes and impaired glucose tolerance in people aged 25 
to 70 years was 11.4 percent (4.5 million people) and 14.6 percent in 2011 respectively. Trend analysis in 2005 to 
2011 showed 35 percent growth in the diabetes prevalence in Iran. The annual direct cost of diabetes in the 
country is estimated to be about 590$ million in 2009 (Esteghamati et al., 2014). Factors of increasing the 
diabetes prevalence in the country include low physical activity, rapid economic transition, urbanization, 
consumption of high-calorie foods and obesity (Farzadfar et al., 2012; Naghavi & Jafari 2007). 
As stated by the international reports, it can be prevented at least 80 percent of heart disease, stroke and type 2 
diabetes by eliminating the main factors causing these diseases (WHO, 2008). Considering the high prevalence 
of diabetes in Iran and likely to increase of its prevalence in the future, the analysis of the  policies and 
programs for prevention and control of diabetes is very important and effective in reducing rates of prevalence of 
diabetes and its complications. Therefore, aim of the study was an analysis of policies and programs related to 
prevention and control of diabetes in Iran in 2014. 
2. Methods 
2.1 Study Design 
This study was an analysis of the diabetes policies and programs in Iran using deductive thematic content 
analysis of key documents. In this study, the health policy triangle framework was used in the data analysis. The 
Walt and Gilson’s policy triangle framework, that has been prepared specifically for study on health field, 
focuses on four fields of policy consist of content, context, process and actors who have a critical role in forming 
policies (Figure 1) (Walt et al., 2008).  
 
Figure 1. Walt and Gilson’s policy triangle framework 
 
2.2 Search Strategy and Document Finding 
PubMed and ScienceDirect databases were searched to find studies about policies and programs for prevention 
and control of diabetes in Iran since 1989 (the first program of the WHO as for the prevention and control of 
diabetes) (Reiber & King, 1991) until July 2014. Key words to search were diabetes, policies, programs, 
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processes, strategies, intervention and Iran. Also, hand searching was conducted among references of identified 
articles. In addition, reports of the international organizations like WHO, International Diabetes Federation (IDF) 
and World Bank (WB) were examined. Furthermore, internal websites such as the ministry of health website 
were searched for finding internal documents. 
Aside from the original documents about the policies and programs of diabetes, the guidelines, survey reports 
and national meeting reports on the formulation and evaluation of the program were examined in the study. The 
included documents for the study were 21 documents: original documents (5), survey reports (2), guidelines (7), 
and national meeting reports on the formulation and evaluation of the program (7) (Table 1). 
 
Table 1. List of analyzed documents in this study 
Original documents 
National diabetes prevention and control program (Delavari et al., 2004a) 
The comprehensive program for prevention and control of diabetes type II, Phase II, Run the 
program in the cities with over a million people (MoHME, 2010) 
National comprehensive program for prevention and control diabetes, the action plan of 
specialized care (Ravaghi et al., 2010) 
National program for prevention and control diabetes type II  in urban areas (Alavi Nia et 
al., 2012) 
Management of specialized care program for diabetes (Ghotbi and Kermanchi, 2013) 
Survey reports 
A National Profile of Non-Communicable Disease Risk Factors in the I.R. Of Iran- Selected 
results of the first survey of Non-Communicable Diseases risk factor surveillance system of 
Iran, 2005 (Delavari et al., 2005) 
I.R. Iran Non-Communicable Diseases, Risk Factors Surveillance, 2008 (Asgari et al., 2008) 
Guidelines 
Principles of Disease Prevention and Care – Non-Communicable Diseases Surveillance 
system - National guidelines (Ghotbi et al., 2008) 
National diabetes prevention and control program for physicians (Delavari et al., 2004f) 
National diabetes prevention and control program for nurses (Delavari et al., 2004e) 
National diabetes prevention and control program for technicians (Delavari et al., 2004g) 
National diabetes prevention and control program for dietitians (Delavari et al., 2004b) 
National diabetes prevention and control program for health workers (Delavari et al., 2004c) 
National diabetes prevention and control program for laboratory technicians (Delavari et al., 
2004d) 
National meeting reports   
National meeting report on the comprehensive diabetes program (Mashhad, October 
2011)(Ghotbi, 17 October 2011) 
National meeting report on the comprehensive diabetes program (Kashan, January 2012) 
(MoHME, 1 January 2012) 
National meeting report on the comprehensive diabetes program (Kerman, April 2012) 
(MoHME, 14 April 2012) 
National meeting report on the comprehensive diabetes program (Yazd, March 2013) 
(MoHME, 3 March 2013) 
Workshop report about evaluation and quality improvement of specialized care program for 
diabetes (Bandar Abbas February 2014)(Ghotbi, 17 Febuary 2014) 
Analytical performance report of the urban phase of the comprehensive diabetes program,  
2012 (Ghotbi, 2012) 
Performance report of the urban phase of  the specialized care program for diabetes, 2013 
(Ghotbi, 2013) 
 
 
www.ccsenet.org/gjhs Global Journal of Health Science Vol. 7, No. 6; 2015 
190 
 
2.3 Data Analysis 
Documents using thematic content analysis were classified, described and analyzed. The documents were sorted 
from old to new chronology and were examined several times by the research team. Afterwards, primarily 
coding of all documents was conducted. Next, Initial codes were put on the main themes based on the study’s 
conceptual framework by the first researcher. After that, the researchers agreed on the data analysis process and 
finally the coding instruction was prepared. Then, all documents were coded and themes were re-classified by 
the researchers using the coding instruction. After the researchers performed the coding, the codes were reviewed 
by the research team. And finally, the consensus was generated on the final codes and themes. MAXQDA 10 
software was used to organize and analyze data. 
3. Results and Discussion 
3.1 Content 
A pilot project for prevention and control of diabetes was implemented in some areas of the country in 1992. The 
project results were evaluated in 1993. The results of the evaluation include the non-standard method for 
screening, the high costs of screening and surveillance for each patient, lack of adequate equipment in the health 
network system to implement the program and the low prevalence of diabetes in the rural areas. The results were 
lead to stopping the program (Delavari et al., 2004a).  
The national diabetes prevention and control program was implemented in the pilot phase in 17 medical 
universities for people over 30 years and pregnant females in 1999 to 2001. After the pilot implementation, the 
program was launched in two phases (rural phase and urban phase) in 2004 and 2010 respectively (Figure 2). 
The target population of the both phases is the high-risk adults older than 30 years and pregnant women. The 
screening in the rural phase was active, but the screening in the urban phase is passive and opportunistic (Azizi 
et al., 2003a; Alavi Nia et al., 2012).  
 
Figure 2. Timeline of the national diabetes prevention and control program in Iran  
 
The overall goal of both of the phases was prevention and control of diabetes and its complications. The specific 
objectives, strategies and outcomes of the program are shown in table 2 (Alavi Nia et al., 2012; Delavari et al., 
2004a). Although the goals and strategies of the program were largely consistent with the objectives of the world 
diabetes program in 1989 (Reiber & King 1991) and the global action plan for prevention and control of NCDs 
in 2013 (WHO, 2013), collaboration with other stakeholders such as the private sector and NGOs and well as the 
important role of social determinants in preventing diabetes through creation of health–promoting is not 
mentioned in the program. 
 
Table 2. Objectives, strategies and outcomes of the program 
Objectives 
primary 
- to reduce the incidence and prevalence of diabetes type II 
- to reduce the prevalence of modifiable risk factors to the condition (obesity, physical inactivity, 
unhealthy diet, etc.) 
secondary - to prevent, reduce and delay the short and long-term complications of diabetes 
tertiary 
- to reduce and delay the incidence of disability and premature death due to the diabetes 
complications 
- to reduce loss of life of people with diabetes 
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Common strategies in 
both phases 
- to gain the support of policy makers  
- to determine  needed resources and the minimum standards for care of diabetes 
- helping the health centers to develop and improve needed laboratory equipment  
- help to develop the reference laboratories for conducting the quality control tests related to 
diabetes 
- help to provide needed medicines, equipment and material for control, monitoring, and 
self-monitoring of diabetes 
- to support of the researches related to diabetes  
- to screen employees of  the trade unions and governmental and  NGOs in the urban areas 
- to screen and increase awareness of  people about diabetes in the special days and places 
Added strategies to the 
urban phase 
- to educate and inform the general population 
- obtaining the government participation in informing society and empowering patients and their 
families 
- to strengthen the referral system in diabetes care 
- appropriate and timely treatment of diabetic patients 
- to strengthen intra and inter-sectoral coordination in providing services to the referred patients 
- to enable the diabetes team at different levels of care 
- to promote the surveillance systems, monitoring and evaluating of diabetes care 
- to increase the international participation in implementing the program 
Outcomes 
- to reduce economic costs due to diabetes and its complications 
- to reduce disabilities due to diabetes and its complications 
- to reduce premature mortality due to diabetes and its complications 
- to improve quality of life and to increase life of patients with diabetes 
 
3.2 Process 
3.2.1 Agenda-Setting 
The National Committee for Diabetes was formed in summer 1996 after releasing the results of many studies 
which showed the high prevalence of diabetes in the country. The objective of the committee formation was the 
provision of the national diabetes program and the training patterns for the public and providers. The committee 
members presented a program with the overall goal of prevention and control of diabetes. The MoHME, in 
coordination with the National Committee for Diabetes, held six workshops related to diabetes for doctors, 
nurses and nutritionists in 1997 and 1998. Afterward, the program was implemented as a pilot plan in 1999 
(MoHME, 2010; Azizi et al., 2003a). 
The reasons into consideration diabetes in Iran can be the WHO report in 1989 and the obligation of member 
states to plan for prevention and control of diabetes in the countries (Reiber & King, 1991), high prevalence of 
diabetes in the country in many researches (Azizi et al., 2003a), the commitment and insistence of the health 
minister for implementing the diabetes program in 1996 (Delavari et al., 2004a) and allocating a budget from 
taxing on sugary drinks to diabetes program approved by the Parliament of Iran (PoI, 2007) which  provided 
valuable funds to start the program. 
3.2.2 Formulation 
The program formulation was based on the WHO instructions and guidelines. Also, the regulatory requirements 
such as the fifth development plan of the country as well as the capacity of the medical universities and 
willingness to implement the program among the board of trustees of the medical universities were considered 
(Ghotbi & Kermanchi, 2013). Despite considering the important issues such as the capacity and coordination 
within the medical universities in formulating the urban phase, but the experiences of successful countries have 
been used very little.  
In formulating the rural phase, the diabetes workshops were held for the chief executives of medical universities 
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in the country for 4 days and more than 270 people. At these meetings, the duties of diabetes team, the 
educational materials for diabetes, and the educational texts for the health workers and the physicians were 
prepared. Also, the workshops were held for the physicians, nurses, nutritionists across the country (Delavari et 
al., 2004a). 
With regard to the increased prevalence of diabetes in the metropolitans, planning to control of diabetes was 
begun in the cities with populations over one million people since 2010. The necessary changes were applied in 
the previous program to perform it in the cities. This program was designed given the breadth and diversity of 
the target population in the metropolitans. After several meetings with the officials and experts of the selected 
medical universities, feedbacks about the program were reviewed. Meanwhile, the educational literatures for 
service providers were revised and also a set of executable instructions was prepared. After making the necessary 
changes in the program, the final program was sent to the medical universities and the program funds were 
distributed among the medical universities (MoHME, 2010). 
The training workshops were held by the Center for Non-Communicable Disease Control for the program 
providers in 2010. Also, the prerequisites for the program implementation were prepared by the medical 
universities and the personnel responsible for implementing the program were trained (Alavi Nia et al., 2012). 
3.2.3 Implementation  
The national diabetes prevention and control program was integrated into the primary health care of the health 
system in October 2004 (Alavi Nia et al., 2012; Ravaghi et al., 2014).The program was not implemented in the 
cities. The reasons for it include lack of the coherent and comprehensive health network and active network 
system needed to provide the services in the cities as well as lack of enough fiscal resources to implement the 
program in the whole country (MoHME, 2010).  
The rural phase was run by the health workers in the rural health centers. The screening for all adults aged 30 
years and older of the villages was implemented in two rounds in 2004 and 2008. But, the screening was done 
once a year for people with pre-diabetes. The medical universities were responsible for implementing the 
program in the rural areas. They could collaborate with the private sector if needed (Delavari et al., 2004a).  
The urban phase was designed in 2009. The program at the urban level is defined in three levels include the first 
level (diabetes units (urban health centers or private clinic) for the screening and patient care), the second level 
(specialized hospitals) and the third level (sub-specialized centers) (Ravaghi et al., 2014).  
After the evaluation and redesign of the program, it was implemented in Tehran and five metropolitans of the 
country in 2010. The other three medical universities were added to the program and meanwhile, the second 
level of specialized services was launched through collaborating with the health and treatment deputies of the 
medical universities. Six and eight other universities joined to the program in 2011 and 2012 respectively 
(Ghotbi & Kermanchi, 2013). 
The main criterion for joining the medical universities in the urban phase is the collaboration between health and 
treatment deputies for the comprehensive and uninterrupted use of the integrated health services (MoHME, 1 
January 2012). To write the operational program is the responsibility of the medical universities. But the program 
must be approved by the MoHME. The operational program should be based on the size of the diabetes problem 
as well as the capacity of executive system in the provinces. The funds will be distributed to the medical 
universities after the operational program approval for a three-month period. Afterward, the funds for the 
program will be placed at the disposal of the universities based on the performance of three-month period 
(Ghotbi & Kermanchi, 2013; Ravaghi et al., 2010). 
In addition to the national diabetes committee, the medical universities have an advisory committee for diabetes. 
This committee is responsible for decision-making, the approval of the operational program and allocating funds 
for implementing the diabetes program at the university level. All diabetic patients, which are under care at the 
health centers, are referred to the hospital to assess the chronic complications once yearly. In some cases, the 
diabetes units are run by the private sector (Alavi Nia et al., 2012). 
3.2.4 Evaluation  
The program was evaluated for the first time using a questionnaire at the six medical universities in 2002. The 
evaluation results showed higher prevalence of diabetes in the cities than in the villages, the highest prevalence 
in the industrial urban areas, higher prevalence in women than in men as well as the program success in the rural 
areas and high consent of implementing the program in the rural population (MoHME, 2010; Farzadfar et al., 
2012). The second evaluation of the program was conducted in 2009. The evaluation results showed the failure 
in the referral system and complications control. Also, there wasn’t a good performance in the control of 
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complications except in the retinopathy control. The evaluation results were used to review and to modify the 
urban program (Ghotbi & Kermanchi, 2013; Delavari et al., 2009). Besides these evaluations, two rounds of the 
Non-Communicable Disease risk factors survey were conducted in 2005 and 2008 which the results are shown in 
table 3 (Asgari et al., 2008; Delavari et al., 2005). 
 
Table 3. Results of two rounds of Non-Communicable Disease risk factors survey in 2005 and 2008 
Indicator 
Indicator of Report 2005 
(percent) 
 Indicator of Report 2008 
(percent) 
Male Female Total  Male Female Total 
The mean fasting blood glucose (mg/dl) 94.6 95.1 94.9  89.51 88.96 89.24 
Percentage of people with high blood glucose 
(> 126 mg/dl) 
5.6 6.1 5.9  9.41 9.97 9.69 
The mean serum cholesterol (mg/dl) 194.6 200.2 197.6  181.4 189.7 185.5 
Percentage of people with high blood 
cholesterol (> 200 mg/dl) 
41 46 43.7  35.1 45.12 40.04 
 
The program evaluation in the urban phase is conducted by the process evaluation indicators at the university 
level every six months. The analytical performance reports are prepared by the medical universities, according to 
pre-prepared forms. These reports are regulated jointly by the program’s health experts at the health deputy and 
the program’s executive focal points at the treatment deputy of the medical universities. Evaluation of the 
program effectiveness is conducted through periodic evaluations during the specific periods as well as the 
external evaluation methods by the headquarters of the ministry of health.  
The program effectiveness indicators include the percentage of people aged 30 years and older covered  by the 
program, the incidence rate of diabetes in people aged 30 years and older, the prevalence rate of diabetes in 
people aged 30 years and older, the incidence rate of disability due to the diabetes , the prevalence rate of 
disability due to the diabetes, the incidence rate of gestational diabetes, as well as the rate of optimal glycemic 
control in the diabetic patients covered by the program, the hypertension prevalence in the diabetic patients and 
the annual incidence of the chronic complications in diabetic patients covered by the program which These 
indicators are calculated by age, sex and geographic area (Ravaghi et al., 2010). 
3.3 Context 
The contextual factors affecting the program implementation in the country include the political and 
administrative factors, the economic and financial factors and the social and cultural factors.  
The political and administrative factors include the capabilities of the health network system in the  
implementation of the program, the possibility of providing the program services at the lowest level of the health 
network system, the existence a system to collect and to report health information from the lower levels to the 
higher levels of the health system (Alavi Nia et al., 2012; Delavari et al., 2004a), difficulty in the referral levels 
of the diabetes program, the shifting of staff responsible for the program implementation (MoHME, 14 April 
2012; Ghotbi & Kermanchi, 2013), lack of adequate cooperation between health and treatment deputies  in the 
medical universities, lack of coordination between the private sector and public sector, limitations of the data 
entry and reporting system in the specialized levels of the program and shortage of manpower and skills needed 
to implement the program (Alavi Nia et al., 2012; Ghotbi, 2013). The results about the limitations of the data 
entry and reporting system and manpower and skills shortages is along with the results of the study of Ravaghi 
and et al. (2014).  
The economic and financial factors include lack of funding for optimal implementation of diabetes program, a 
lack of health insurance coverage for most of diagnostic services, particularly advanced services, lack of equal 
and constant access to the treatment requirements at the different times of the year , the unavailability of some 
types of insulin at the sometimes, lack of access to syringes with high quality, lack of diagnostic facilities in the 
second level of the program , low number of equipped laboratories in the rural health centers and lack of access 
and high costs of the self-monitoring facilities like glucometer (Ghotbi, 17 October 2011; Ghotbi, 2012).  
The social and cultural factors include lack of harmony and cooperation of the cultural, social and economic 
streams in the country, low level of health literacy in the country, lack of access to healthy living choices, 
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culturally and economically(Ghotbi, 17 Febuary 2014). 
3.4 Actors 
Participants in formulating the rural phase included the national diabetes committee members, the 
representatives of the medical universities; Department of Endocrinology and Metabolic of Center for 
Non-communicable Disease Control, Center for Network Development and Health Promotion, Bureau of 
Population & Family Health, and Office of Community Nutrition Improvement of Ministry of Health and 
Medical Education (Delavari et al., 2004a). Participants in formulating the urban phase included Department of 
Endocrinology and Metabolic of Center for Non-communicable Disease Control, Office of hospital 
administration and Clinical Service Excellence, Endocrinology & Metabolism Research Institute of Tehran 
University of Medical Sciences, the chancellors and vice- chancellors of the medical universities, Iranian Society 
of Nephrology, the financial director of treatment deputy, the general manager of Center for Non-communicable 
Disease Control and the program experts at the medical universities (Alavi Nia et al., 2012).  
Although the more stakeholders involved in the urban program formulation compared to the rural program, but 
like the rural program, most of them were internal stakeholders and the key stakeholders outside of the health 
sector did not participate in the program formulation. As the results of studies show a low collaboration among 
various stakeholders in the policy formulation in developing countries (Kilic et al., 2015; Mendis & Chestnov, 
2013). 
4. Conclusions 
Despite the attention to the diabetes problem and the beginning of the program and its integration into the health 
network system about 10 years ago, the prevalence of diabetes and its complications is rising in the country. 
Therefore, it is required that the health officials and policy makers focus more on the prevention issues and 
reducing risk factors in the society. The study limitations include the only use of the policy documents in the 
policy analysis as well as lack of using NGO's documents in the policy analysis. 
Given the large population in the cities were covered by the diabetes urban program in the last four years, It is 
hoped the program will reduce the diabetes incidence and prevalence in the country. To achieve this, the 
physicians should use the guidelines regarding glycemic control for the treatment of the diabetic patients. The 
revision of the insurance contract as well as increase of insurance premium is recommended for the patients who 
did not attempt to control their blood sugar. 
Also for increasing the program effectiveness, in addition to strengthen the referral system, the government 
should allocate more funds and importance to the educational programs. Furthermore, NGOs and the private 
sector should contribute to the formulation and implementation of the diabetes prevention and control programs 
in the future. In addition, the government should provide adequate medical facilities for prevention and control 
of diabetes in the country. And also, with regard to the important role of the community members and patients in 
the program success and the patient- oriented nature of diabetes, they should pay more attention to the their 
health through proper nutrition, adequate physical activity and awareness of the physical health status. 
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